Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors

Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors

US Patent 8546435 · Granted Oct 1, 2013

Estimated economic value: $717,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-azaindazole derivatives as adenosine receptor antagonists2025
Continuous, solvent-free and non-enzymatic peptide synthesis by reactive extrusi2023
Use of macimorelin in assessing growth hormone deficiency in children2023
Substituted heterocyclic compounds as allosteric modulators of group II metabotr2022
Stapled peptides and uses thereof2022
Process for preparation of bioorganic nylon polymers and their use as antibacter2022
Method and system for protected communication between a mobile unit coupled to a2020
Method for preventing deactivation of online services in a vehicle2020
Method and information system for informing a driver of a vehicle regarding the 2019
Method and information system for informing a driver of a vehicle regarding the 2018
Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use th2017
Modulators of the nuclear hormone receptor ROR2017